CATHETER ABLATION THERAPY FOR SUPRAVENTRICULAR TACHYCARDIA IN CHILDREN

儿童室上性心动过速的导管消融治疗

基本信息

  • 批准号:
    05670705
  • 负责人:
  • 金额:
    $ 1.02万
  • 依托单位:
  • 依托单位国家:
    日本
  • 项目类别:
    Grant-in-Aid for General Scientific Research (C)
  • 财政年份:
    1993
  • 资助国家:
    日本
  • 起止时间:
    1993 至 1995
  • 项目状态:
    已结题

项目摘要

Fourteen cases of supraventricular tachycardia with manifest or concealed Wolff-Parkinson-White syndrome in children were performed radiofrequency catheter ablation. The optimal size of catheter was 7 French in patients over 10 years old, and 6 French in patients less than 10 years old. Accessory pathway potential were recorded in 5 of 6 cases. The position of accessory pathway potential and earliest atrial activation site were not always same. Radiofrequency accessory pathway ablation were succeeded in all cases who were recorded accessory pathway potential. Total energy for ablation was 20 to 40 Watt sec. All cases succeeded ablation in a few seconds. Ablation were succeeded in 2 of 4 right pathways and 6 of 10 left pathways. Ablation were succeeded in 4 of 9 (44%) manifest pathways and 4 of 5 (80%) concealed pathways. However it was unsuccessful in septal and multiple pathway. Success rate was 8 of 14 cases (57%) , 8 of 15 pathways (53%). The successful ablation site was 1) Kent potential documentation, 2) A wave amplitude equal and over 0.4 mV,3) A/V ratio equal and over 0.2,4) shortest VA or QA interval measured from peak V wave to peak A wave during tachycardia or ventricular pacing. However there were no absolute optimal site if we use these indexes. Moderate aortic regurgitation was detected in one case after ablation. This complication was not due to ablation method but due to inflexibility of catheter. Catheter ablation was useful therapy for supraventricular tachycardia in children.
本文报告14例儿童室上性心动过速合并明显或隐匿性预白色综合征的射频消融治疗。10岁以上患者的最佳导管尺寸为7 French,10岁以下患者的最佳导管尺寸为6 French。6例中5例记录到旁道电位。旁路电位的位置和最早心房激动部位并不总是相同的。所有记录到旁道电位的患者均成功消融旁道。消融总能量为20 - 40 W/s。所有病例均在几秒钟内成功消融。4例右径路消融成功2例,10例左径路消融成功6例。9条显性径路中4条(44%)消融成功,5条隐性径路中4条(80%)消融成功。但间隔和多径路手术均未成功。成功率为8/14例(57%),8/15条路径(53%)。成功消融部位为:1)记录到肯特电位; 2)A波振幅等于或大于0.4 mV; 3)A/V比值等于或大于0.2;但是,如果我们使用这些指标,没有绝对的最佳网站。1例消融后检测到中度主动脉瓣返流。这种并发症不是由于消融方法,而是由于导管的可扩展性。导管消融术是治疗儿童室上性心动过速的有效方法。

项目成果

期刊论文数量(12)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
牛丿濱大也、住友直方、堀切千賀子、他: "頻拍の成立に房室結節の遅伝導路の伝導遅延を必要とした房室回帰性頻拍の1例" 日本小児科学会誌. 100. (1996)
Daiya Ushihama、Naokata Sumitomo、Chikako Horikiri 等:“房室复发性心动过速需要房室结慢传导通路传导延迟才能形成心动过速”,日本儿科学会杂志 100。(1996 年) )
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
住友直方、牛ノ濱大也、唐沢賢祐、他: "小児房室回帰性頻拍に対する高周波アブレーション" 日本小児科学会誌. 97. 959-964 (1993)
Naokata Sumitomo、Daiya Ushinohama、Kensuke Karasawa 等人:“射频消融治疗小儿房室复发性心动过速”日本儿科学会杂志 97. 959-964 (1993)。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
牛ノ濱大也、住友直方、山下恒久、他: "膜様部心室中隔欠損に合併した心室頻拍に高周波カテーテルアブレーションを施行した1例" 心電図. 16(発表予定). (1996)
Daiya Ushinohama、Naokata Sumitomo、Tsunehisa Yamashita 等人:“高频导管消融治疗与膜性室间隔缺损相关的室性心动过速病例”16(待出版)。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Hiroya Ushinohama, Naokata Sumitomo, Tunehisa Yamashita, Hiroyuki Izumi, Kensuke Harada: "Radiofrequency catheter ablation to ventricular tachycardia with membranous ventricular septal defect" Jpn.J.of Electrocardiology. 16 (in press). (1996)
Hiroya Ushinohama、Naokata Sumitomo、Tunehisa Yamashita、Hiroyuki Izumi、Kensuke Harada:“射频导管消融治疗膜性室间隔缺损室性心动过速”Jpn.J.of Electrocardiology。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
牛ノ濱大也、住友直方、堀切千賀子、他: "頻拍の成立に房室結節の遅伝導路の伝導遅延を必要とした房室回帰性頻拍の1例" 日本小児科学会誌. 100(発表予定). (1996)
Daiya Ushinohama、Naokata Sumitomo、Chikako Horikiri 等人:“房室复发性心动过速需要房室结慢传导通路传导延迟才能建立心动过速的病例”日本儿科学会杂志 100(演示文稿预定 100) )(1996)。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

SUMITOMO Naokata其他文献

SUMITOMO Naokata的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

相似海外基金

InSPACE-VT_Development and Validation of Virtual Pace Mapping to Guide Catheter Ablation of Ventricular Tachycardia
InSPACE-VT_虚拟起搏测绘的开发和验证以指导室性心动过速导管消融
  • 批准号:
    EP/Z001145/1
  • 财政年份:
    2024
  • 资助金额:
    $ 1.02万
  • 项目类别:
    Fellowship
Study to elucidate the modification effect of excimer laser catheter ablation, ELCA on lipid plaque components in patients with acute coronary disease
阐明准分子激光导管消融、ELCA对急性冠心病患者脂质斑块成分的修饰作用的研究
  • 批准号:
    22K16156
  • 财政年份:
    2022
  • 资助金额:
    $ 1.02万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Photoacoustic Imaging to Guide Catheter Ablation of Cardiac Arrhythmias
光声成像指导心律失常导管消融
  • 批准号:
    10453093
  • 财政年份:
    2022
  • 资助金额:
    $ 1.02万
  • 项目类别:
Photoacoustic Imaging to Guide Catheter Ablation of Cardiac Arrhythmias
光声成像指导心律失常导管消融
  • 批准号:
    10610912
  • 财政年份:
    2022
  • 资助金额:
    $ 1.02万
  • 项目类别:
Insertable Cardiac Monitor-Guided Early Intervention to Reduce Atrial Fibrillation Burden Following Catheter Ablation (ICM-REDUCE-AF Trial)
可插入心脏监护仪引导的早期干预以减少导管消融后心房颤动的负担(ICM-REDUCE-AF 试验)
  • 批准号:
    10434168
  • 财政年份:
    2021
  • 资助金额:
    $ 1.02万
  • 项目类别:
A Trial to Evaluate Renal Artery Denervation in Addition to Catheter Ablation to Eliminate Atrial Fibrillation (ERADICATE-AF II)
评估除导管消融之外的肾动脉去神经术以消除心房颤动的试验 (ERADICATE-AF II)
  • 批准号:
    10470105
  • 财政年份:
    2021
  • 资助金额:
    $ 1.02万
  • 项目类别:
RADIOMIC APPROACHES TO IMPROVE TARGETING FOR ATRIAL FIBRILLATION CATHETER ABLATION
提高心房颤动导管消融靶向的放射学方法
  • 批准号:
    10447164
  • 财政年份:
    2021
  • 资助金额:
    $ 1.02万
  • 项目类别:
CAMERA-MRI II: Catheter Ablation versus Medical Rate Control in Atrial Fibrillation with Systolic Heart Failure and Myocardial Fibrosis - an MRI guided Multi-Centre Randomised Controlled Trial
CAMERA-MRI II:房颤伴收缩性心力衰竭和心肌纤维化的导管消融与药物心率控制 - MRI 引导的多中心随机对照试验
  • 批准号:
    nhmrc : 2003047
  • 财政年份:
    2021
  • 资助金额:
    $ 1.02万
  • 项目类别:
    Postgraduate Scholarships
RADIOMIC APPROACHES TO IMPROVE TARGETING FOR ATRIAL FIBRILLATION CATHETER ABLATION
提高心房颤动导管消融靶向的放射学方法
  • 批准号:
    10316365
  • 财政年份:
    2021
  • 资助金额:
    $ 1.02万
  • 项目类别:
A Trial to Evaluate Renal Artery Denervation in Addition to Catheter Ablation to Eliminate Atrial Fibrillation (ERADICATE-AF II)
评估除导管消融之外的肾动脉去神经术以消除心房颤动的试验 (ERADICATE-AF II)
  • 批准号:
    10212737
  • 财政年份:
    2021
  • 资助金额:
    $ 1.02万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了